Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
about
Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonists.Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis.Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri.Regulatory T cells resist virus infection-induced apoptosisMice completely lacking immunoproteasomes show major changes in antigen presentationEvaluation of non-reciprocal heterologous immunity between unrelated virusesInhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expressionImmunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes.Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice.Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations.Private specificities of CD8 T cell responses control patterns of heterologous immunityUnusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.The complement system: its importance in the host response to viral infection.Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1.Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.High frequencies of virus-specific CD8+ T-cell precursors.Heterologous Immunity and Persistent Murine Cytomegalovirus InfectionEvaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.Studies on the neutralization of herpes simplex virus. VIII. Significance of viral sensitization for inactivation by complement.Studies on the neutralization of herpes simplex virus. IX. Variance in complement requirement among IgG and IgM from early and late sera under different sensitization conditions.Studies on the neutralization of herpes simplex virus. X. Demonstration of complement-requiring neutralizing (CRN) and slow-reacting CRN (s-CRN) antibodies in late IgG.Complement requirement for virus neutralization by antibody and reduced serum complement levels associated with experimental equine herpesvirus 1 infection.Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis.Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.rs2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis C patients.Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection.Neutralization of sendai virus by the IgG subclass antibodies of the guinea pig.
P2860
Q33826847-A00B4AC0-FAEE-4041-95F6-CE48043CD474Q33882896-4735918F-9649-4D3E-96CD-E62366EC38E6Q34931500-D6EA9871-D04A-4248-A415-2471D37C5296Q35115564-508B31D9-7721-4F62-B7D8-CECC4B6B00C8Q35685470-1880C99C-50FD-4D7D-9B92-541C6E328D0BQ35706798-E0C8EA7C-838E-4E23-8AE2-44D3B8AB39E3Q36335418-7D3E0D03-A959-46CE-ACA5-B8AF5FE9733AQ36400369-685D111C-3619-4DD2-BA83-EC78A4D8983EQ36401170-0A9E6C47-E7F9-467E-97EC-37954E59CED3Q36401710-3F15C5B2-B1AE-445B-9E4A-73AD111EB9D6Q36403228-BACFA7F7-93A9-49F5-85E3-B9FBA76AC1E6Q36559797-E1D0BA7F-B6BD-4736-9A52-753FEBF3801BQ37066281-2C22AD39-7A42-44DB-A3C4-7A7EC2CB6CC3Q37272136-8F24C94C-6C25-4858-A29F-4FDBA0D8E35AQ37452067-AA625365-D5C8-4658-A4AD-9B614CF40F38Q37452503-8189DF28-29C8-498A-84B5-ADD80C31743FQ37560728-CA405D80-21BF-444C-863A-413EF2DE1BF7Q39580367-3A82A33E-D758-4BA1-8667-243BFE67641BQ40080303-93F1062D-1131-49D7-8094-430706D98548Q40185573-FC0AF384-BE54-43F0-A3E2-1C0E4821B4CDQ40276491-A8791EC8-F553-4501-823E-EC80A9A176BAQ40614142-55419B8E-1A37-4527-9CEC-BA93EF15A747Q41055245-FA9FB036-66DE-430B-9F16-97B565809AF6Q41195473-2A816B44-D70C-48AE-8CB2-42D7446E47E3Q42208077-72118EAB-6CA5-4410-B21D-1C91A4081363Q45733086-6DDB82A8-A1B3-41AF-BB8B-22F4A28C2F41Q45799043-EE3611DC-FADA-4DBF-B2EB-D5D329BD2B34
P2860
Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh-hant
name
Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
@en
Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
@nl
type
label
Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
@en
Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
@nl
prefLabel
Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
@en
Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
@nl
P2093
P1433
P1476
Antibody-complement interactions with purified lymphocytic choriomeningitis virus.
@en
P2093
Lampert PW
Oldstone MB
Welsh RM Jr
P356
10.1016/0042-6822(76)90060-X
P407
P577
1976-08-01T00:00:00Z